EDITORIAL: Eye-opening move against drug costs - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
December 21, 2018 Newswires
Share
Share
Post
Email

EDITORIAL: Eye-opening move against drug costs

Buffalo News (NY)

Dec. 21--When Independent Health sent a letter informing eye specialists that using the $2,000-a-dose brand name drugs to treat age-related macular degeneration would be met with consequences, the insurer struck a nerve. Doctors were told to use off-label Avastin, instead. It runs about $50 a dose.

It was the right move. Now Congress needs to act.

Independent Health's CEO, Dr. Michael Cropp, has been vocal about the high cost of health care, penning several opinion pieces for this newspaper. The decision to begin crunching data five years ago to "weigh quality and cost of care provided by specialists" falls in line with the maverick approach by the insurer. As News staff reporter Scott Scanlon wrote, its letter to eye specialists about a "potential fee schedule reduction" was the first time an insurer in this region, and perhaps the nation, raised the possibility of financial penalties to doctors who ignore a median standard of care determined by data comparisons.

The insurer revised the potential policy for 2019 after getting feedback from eye doctors. Instead, the company asks doctors to take a measured approach -- one that should already be employed -- by starting all treatment regimens with Avastin. If it does not work well, then go to the more expensive drugs.

Independent Health is taking a strong stand, one necessary against the backdrop of an industry that has set exorbitant prices for some drugs.

Still, not everyone is pleased. Dr. Gareth Lema told The News: "They're asking us to play God." Lema is a Buffalo eye surgeon whose two-doctor practice received one of the letters informing Lema that the office was not meeting the preferred threshold for Avastin use.

It is not the case here, but some specialists elsewhere prescribing the higher-cost medication are also reimbursed at higher rates. Independent Health raised the reimbursement for Avastin to bring it more in line with the expensive drugs.

Dr. John Thompson, past president and chairman of health policy with the American Society of Retina Specialists, said most ophthalmologists and retina specialists start macular degeneration patients on Avastin for "three to six months" but move on to costlier drugs, if necessary. He also raised the specter of more frequent injections with the Independent Health policy and questioned whether doctors with patients in poorer communities and those with higher risk of blood clots and stroke would be adversely affected. These are good points but, under the circumstances, must be measured against the backdrop of out-of-control drug costs that threaten American health care.

Congress must act. The outgoing GOP-controlled House wasted precious time trying to dismantle the Affordable Care Act. The Democrats must make health care costs its priority and the should start by leveraging vast buying power to secure bulk discounts for expensive drugs.

Independent Health's bold move should be a wake-up call to doctors who do a disservice to patients and the taxpaying public by choosing the higher-cost path when there is a less expensive alternative.

___

(c)2018 The Buffalo News (Buffalo, N.Y.)

Visit The Buffalo News (Buffalo, N.Y.) at www.buffalonews.com

Distributed by Tribune Content Agency, LLC.

Older

Hailstones like tennis and golf balls fall around Sydney

Newer

Major Auto Insurer Pays Six-Figure Award In Bad Faith Case

Advisor News

  • Survey: Most Americans still feel prosperous despite economic worries
  • SEC settlement would require Tai Lopez, two others, to pay $6.8 million
  • The Gen Z money paradox
  • NAIFA applauds final SECURE 2.0 regulations
  • What will Democrats in Congress do about healthcare and retirement?
More Advisor News

Annuity News

  • AM Best Affirms Credit Ratings of Global Atlantic Financial Group Limited and Its Subsidiaries
  • Best’s Market Segment Report: AM Best Maintains Stable Outlook on US Life/Annuity Insurance Segment
  • AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
  • Boomers want retirement protection, but their actions don’t match their mindset
  • NAIC task force to address LTC riders
More Annuity News

Health/Employee Benefits News

  • States push short-term insurance as healthcare costs climb
  • Study Findings on Managed Care Are Outlined in Reports from Massachusetts General Hospital (A RUC Rescue of Primary Care?): Managed Care
  • Two May Work for You As One
  • AM Best Affirms Credit Ratings of Ameriprise Financial, Inc. and Its Subsidiaries
  • Court: California can mandate free abortions; insurers can charge for births
More Health/Employee Benefits News

Life Insurance News

  • AM Best Affirms Credit Ratings of Ameriprise Financial, Inc. and Its Subsidiaries
  • AM Best Takes Various Credit Rating Actions on Certain Subsidiaries of Auto-Owners Insurance Group
  • AM Best Affirms Credit Ratings of Global Atlantic Financial Group Limited and Its Subsidiaries
  • AM Best Downgrades Credit Ratings of CICA Life Insurance Company of America
  • AM Best Upgrades Credit Ratings of CTBC Insurance Company Ltd
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • OpenRoad Insurance Data Shows 40% of Collector Vehicles Are Model Year 1980 or Newer
  • Insurvoice Lets Independent Insurance Agency Owners Analyze Every Customer Call in ChatGPT or Claude
  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.